Exavir Therapeutics Completes $4M Seed Financing from Key Investors

other

▤ Summary

Financing led by AlleyCorp with participation from Gilead Sciences to support the development of ultra-long-acting integrase inhibitors Financing led by AlleyCorp with participation from Gilead Sciences to support the development of ultra-long-acting integrase inhibitorsFinancing led by AlleyCorp with participation from Gilead Sciences to support the development of ultra-long-acting integrase inhibitors Financing led by AlleyCorp with participation from Gilead Sciences to support the development of ultra-long-acting integrase inhibitors

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies